Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae
Abstract Background Carbapenems represent the first line treatment of serious infections caused by drug-resistant Klebsiella pneumoniae. Carbapenem-resistant K. pneumoniae (CRKP) is one of the urgent threats to human health worldwide. The current study aims to evaluate the carbapenemase inhibitory p...
Main Authors: | Mahmoud Saad Abdel-Halim, Amira M. El-Ganiny, Basem Mansour, Galal Yahya, Hemat K. Abd El Latif, Momen Askoura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12866-024-03214-7 |
Similar Items
-
Development of a quadruple qRT-PCR assay for simultaneous identification of hypervirulent and carbapenem-resistant Klebsiella pneumoniae
by: Zhixiang Xu, et al.
Published: (2024-01-01) -
The evolutionary mechanism of non-carbapenemase carbapenem-resistant phenotypes in Klebsiella spp
by: Natalia C Rosas, et al.
Published: (2023-07-01) -
Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae
by: Yun Wu, et al.
Published: (2024-06-01) -
Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
by: Congcong Liu, et al.
Published: (2025-01-01) -
Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
by: Lin Di, et al.
Published: (2018-10-01)